AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2016
Apr 25, 2016
35021_dirs_2016-04-25_63f29198-d024-4ce4-879d-8a5d622b198d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2016-04-14
Reporting Person: WISCONSIN ALUMNI RESEARCH FOUNDATION (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 469484 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Purchase Warrants | $3.04 | 2021-04-20 | Common Stock (469484) | Direct |
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4